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Abstract.  Receptor-linked tyrosine phosphatases regu- 
late cell growth by dephosphorylating proteins in- 
volved in tyrosine kinase signal transduction. The leu- 
kocyte common antigen-related (LAR) tyrosine 
phosphatase receptor has sequence similarity to the 
neural cell adhesion molecule N-CAM and is located 
in a chromosomal region (lp32-33) frequently altered 
in neuroectodermal tumors. To understand the func- 
tion of receptor-linked tyrosine phosphatases in neural 
development, we sought to identify LAR isoforms 
preferentially expressed in the nervous system and cel- 
lular processes regulating LAR alternative splicing. 
We report here the isolation of a series of rat LAR 
cDNA clones arising from complex combinatorial al- 
ternative splicing, not previously demonstrated for the 
tyrosine phosphatase receptor gene family in general. 
Isoforms included: (a) deletions of the fourth, sixth 
and seventh fibronectin type III-like domains; (b) an 
alternatively spliced novel cassette exon in the fifth 
fibronectin type IJI-like domain; (c) two alternatively 
spliced novel cassette exons in the juxtamembrane re- 
gion; (d) a retained intron in the extracellular region 
with in-frame stop codons predicting a secreted LAR 
isoform; and (e) an LAR transcript including an alter- 
native 3' untranslated region containing multiple 
stretches of tandem CAG repeats up to 21  repeats in 
length. This number of repeats was in the range found 
in normal alleles of genes in which expansions of 
repeats are associated with neurodegenerative disease 
and the genetic phenomenon of anticipation. RT-PCR 
and Northern analysis demonstrated that LAR alterna- 
tive splicing occurred preferentially in neuromuscular 
tissue in vivo and in neurons compared to astrocytes 
in vitro and was developmentally regulated. Alterna- 
tive splicing was also regulated in PC12  cells by NGF, 
in 3T3 fibroblasts  by cell confluence and in sciatic 
nerve and muscle subsequent to nerve transection. 
Western blot analysis demonstrated that alternatively 
spliced cassette exons result in the presence of corre- 
sponding amino acid segments of LAR protein in vivo. 
These studies suggest specialized functions of LAR 
isoforms in the nervous system and support our hy- 
pothesis that LAR-like tyrosine phosphatase receptors 
play a role in neural development and regeneration. 
p 
ROTEIN tyrosine phosphorylation  is a basic mechan- 
ism controlling cell proliferation,  differentiation and 
neurite outgrowth. Growth factors which regulate cell 
growth in the nervous system via tyrosine kinase receptors 
include fibroblast  growth factor, epidermal growth factor, 
and the neurotrophins  such as NGF, brain-derived  growth 
factor, and neurotrophins-3  and -4 (Cross and Dexter, 1991; 
Chao,  1992; Ip  et  al.,  1992). Abundant  expression  of 
non-receptor tyrosine kinases such as pp60 .... and p59~  n in 
developing neurons and their enrichment in growth  cone 
fractions  suggests that non-receptor tyrosine kinases  also 
modulate neuronal development  and plasticity  (Matten  et 
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al., 1990; Ignelzi et al.,  1994). The discovery of receptor- 
linked protein tyrosine phosphatases  (PTPs) t has led to the 
hypothesis that extracellular cues such as growth factors and 
cell surface molecules regulate cell growth by modulating 
activity  of both tyrosine kinase  and tyrosine phosphatase 
receptors.  These receptors would  interact directly or in- 
directly to ultimately  determine the net effect of multiple 
growth or differentiating signals (Fischer et al., 1991; Wal- 
ton and Dixon,  1993; Vogel et al.,  1993; Penninger et al., 
1993). 
1. Abbreviations  used in this paper:  ANOVA, analysis of variance; FNHI, 
fibronectin  type HI: HPTPS, human PTPS; KLH, keyhole limpet hemacya- 
nin; LAR, leukocyte common antigen-related  gene; MPTP~, mouse PTPS; 
PD,  postnatal day; PTP, protein tyrosine phosphatase; RT, reverse  tran- 
scription; VASE, variably alternatively spliced exon. 
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linked PTPs have been cloned (reviewed in Charbonneau and 
Tonks,  1992; Walton and Dixon,  1993). The human leuko- 
cyte common antigen-related  (LAR) gene was the second 
identified member of the receptor-linked PTP gene family 
(Streuli et al.,  1988). It consists of an extracellular region 
with three Ig-like and eight fibronectin type IH-like (FNIII) 
domains and a cytoplasmic region containing  two tyrosine 
phosphatase domains typical of receptor PTPs (see Fig.  1). 
Ig and FNUI domains are motifs characteristic of cell adhe- 
sion  and  extracellular  matrix  molecules  (Reichardt  and 
Tomaselli,  1991;  Edelman  and  Crossin,  1991).  Sequence 
analysis of LAR Ig and FNIII domains revealed significant 
sequence similarity to domains in the neural cell adhesion 
molecule N-CAM,  a  neuronal  surface glycoprotein which 
mediates cell adhesion and neurite outgrowth by homophilic 
and  heterophilic  binding  (Edelman  and  Crossin,  1991; 
Rutishauser,  1993; Doherty and Walsh, 1994). N-CAM and 
similar  cell  adhesion  molecules  modulating  neurite  out- 
growth such as L1, TAG-l, and fasciculin II lack intrinsic ki- 
nase or phosphatase  activity (Doherty and Walsh,  1994). 
LAR can therefore be viewed as a "hybrid" molecule poten- 
tially combining both cell adhesion and tyrosine phosphatase 
functions. This feature of LAR combined with observations 
in Drosophila that LAR is central  nervous system specific 
and is present primarily along axons (Tian et al.,  1991) and 
that mammalian LAR is expressed by neurons and regulated 
by development, NGF, and cell confluence (Longo, E  M., 
J.  P.  Barnes,  and J.  A.  Martignetti.  1991.  Soc. Neurosci. 
Abstr. 17:762; Longo et al.,  1993), suggested that LAR con- 
stitutes  a  novel receptor prototype regulating  neurite  out- 
growth and pathfinding  during neural development. 
Four additional  mammalian  receptor-linked  PTP family 
members have been discovered also containing both Ig and 
FNIII extracellular domains. In most cases, little is known 
about  their  potential  alternative  splicing.  Mouse  PTP6 
(MPTP&  Mizuno  et  al.,  1993;  human  analog  [HPTPt]: 
Krueger  et al.,  1990)  is  expressed  in brain,  kidney,  and 
heart.  The use of alternative  transcription  start  sites pro- 
duces isoforms with one or three Ig domains while poten- 
tial alternative splicing generates transcripts with either four 
or eight FNRI domains. RPTP# is expressed in brain, lung 
and heart and promotes homophilically mediated cell-cell 
adhesion of insect cells (Gebbink et al.,  1991,  1993; Brady- 
Kalnay et al.,  1993). RPTPr is expressed in a wide range of 
tissues including hippocampus, cortex, liver, kidney, and in- 
testine and is developmentally regulated (Jiang et al., 1993). 
R-PTP-r also promotes homophilically  mediated  cell-cell 
adhesion of insect cells (Jiang et al., 1993; Sap et al., 1994). 
PTP NE-3 (Walton et al.,  1993), PTP-P1 (Pan et al.,  1993), 
CPTP-1 (Sahin and Hockfield,  1993), and RPTP-a (Yan et 
al.,  1993) are the same receptor-linked  PTP which is ex- 
pressed as larger ("~8 kb) and shorter (~6 kb) transcripts. 
The larger form has been detected in multiple tissues and cell 
lines including brain,  heart, lung,  testes, liver, and kidney. 
The shorter transcript is selectively expressed in neural tis- 
sue and  cells including  cortex,  olfactory neuroepithelium 
and PC12 cells and is developmentally regulated. The mech- 
anism by which the two transcripts  are generated has not 
been directly determined but may involve alternative splic- 
ing.  Pan et al. (1993) demonstrated by cDNA and genomic 
sequencing that intracellular alternative splicing generates a 
4.8-kb  isoform  of PTP-P1  (PTP-PS)  in  which  the  second 
tyrosine phosphatase domain is absent. 
The first-discovered receptor-linked PTP was leukocyte- 
specific  CIM5  (leukocyte common  antigen)  which  in  re- 
sponse to T cell receptor stimulation activates the Sre family 
tyrosine kinases  p56  ~c~ and p59  frn by dephosphorylating  a 
site at their carboxyl terminus  (Charbonneau  et ai.,  1988; 
Penninger et al.,  1993). Alternative splicing of extracellular 
domain  CD45  exons  generates  distinct  isoforms  that  are 
differentially associated with lymphocyte proliferation, mat- 
uration,  activation,  and  life  span  (Michie  et  al.,  1992; 
Penninger  et al.,  1993).  Alternatively  spliced  CD45  iso- 
forms also differentially interact with different ligands.  For 
example, low molecular weight CD45 interacts with cell sur- 
face CD2 molecules while a larger CD45 isoform preferen- 
tially associates with the integrin receptor LFA-a (Sehraven 
et al.,  1990;  Dianzani  et al.,  1992). 
Previous Northern analysis of rat LAR expression in the 
nervous  system from the single copy gene suggested that, 
like CIM5,  variant  LAR mRNA transcripts  are  also pro- 
duced (Longo et al., 1993). In this study we report that LAR 
transcripts are alternatively spliced and that splicing is regu- 
lated during development and by denervation, NGF-induced 
PC12 cell differentiation  and cell confluence.  We demon- 
strate a complex array of nervous system-preferential LAR 
extracellular and intraeellular alternative splicing which in- 
eludes deletions of specific FNIII domains  and insertions 
of novel  exons  into  extracellular  and juxtarnembrane  re- 
gions. These forms of alternative splicing and these modes 
of splicing regulation have not previously been observed in 
the  general  family  of receptor-linked  PTP genes.  Highly 
regulated combinatorial alternative splicing of cell adhesion 
and other motifs in LAR suggests a mechanism by which 
LAR, and other receptor-linked PTPs, may regulate neural 
development. These forms of PTP alternative splicing may 
represent a fundamental mechanism regulating neural devel- 
opment and regeneration. The peptide sequence and nomen- 
clature of the first two novel LAR exons described here have 
been reported  in  abstract  form (Zhang,  J.  S.,  and  F.  M. 
Longo.  1992. Soc. Neurosci. Abstr. 18:949a;  Zhang, J. S., 
and F. M. Longo.  1993.  Soc. Neurosci. Abstr. 19:1308a). 
Materials and Methods 
Nomenclature 
Mammalian LAR cDNA clones reported thus far correspond to the ~8-kh 
human LAR transcript originally described by Streuli et al.  (1988).  Rat 
cDNA clones isolated from hypothalamus (Pot  et al., 1991), fibroblast (Yu 
et al.,  1992),  whole brain (Longo et al.  1993),  and muscle (Zhang and 
Goldstein, 1991) are rat analogs of  the human *8-kb isoform. Since the "~8- 
kb isoform is the common and predominant LAR form reported, we will 
refer to it as "constitutive" LAR.  The isoforms predicted by the cDNA 
clones in this study containing insertions and deletions compared to "~8-kh 
human and rat LAR will be referred to as "alternative  ~ isoforms. 
Isolation and Sequencing of  Rat LAR cDNA Clones 
For each round of cDNA library screening, approximately 400,000 phage- 
mid plaques were screened from one of the two following Lambda Zap II 
phngemid rat brain cDNA libraries (Stratngene Corp., La Jolla, CA): adult 
whole brain and adult hippocampus.  Libraries were screened with 3ep_ 
labeled oligonucleotide probes using the protocol and  reagents recom- 
mended by Stratngene Corp. Positive clones were isolated according to the 
Stratagene protocol and nucleotide sequences were determined by the chain 
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successive oligonucleotide primers (scquenase 2.0 kit protocol and reagents 
from United States Biochemical Corp., Cleveland,  OH). Regions with am- 
biguity  were sequenced  from the opposite  direction and by using single- 
stranded template.  Guanine and cytosine-rich regions  were sequenced  by 
Taq DNA polymerase and 7-deaza GTP on single-stranded DNA templates 
(GENE-ATAQ sequencing  kit and protocol from Pharmacia LKB Biotech- 
nology, Piscataway, NJ). 
Cloning and Sequencing of  lntrons 
High molecular weight DNA was isolated as described (Sambrook et al., 
1989). In brief, adult Sprague-Dawley  rat brain was homogenized  in SDS 
lysis buffer followed by treatment with proteinase K at 65°C overnight with 
shaking (Sambrook et al.,  1989).  Lysis  mixture was  extracted  by phe- 
nol/chloroform and DNA was isolated by ethanol precipitation. PCR was 
performed with 2/zg genomic DNA template and primers flanking putative 
splice junctions as described in the figure legends. PCR products were iso- 
fated from agarose gels by using glass milk (Geneclean kit; BIO 101, La 
Jolla, CA) or gelase enzyme (Epicentre Technologies Corp., Madison, WI), 
subeloned into the pCR vector (Invitrogen,  San Diego, CA, manufacturer's 
reagents  and protocol) and sequenced  using successive  oligonucleotide 
primers. 
RNA Isolation from 7issues 
Brain, spinal cord,  heart, nerve,  and muscle tissue was dissected  from 
Sprague-Dawley  rats at the ages indicated  in figure legends,  immediately 
frozen on dry ice powder and stored at -70°C. POly(A) RNA was directly 
isolated from tissue and cultured cells by incubation of samples  in tissue 
lysis buffer with oligo dT cellulose (type 3; Collaborative Research,  Inc., 
Waltham, MA) using a standard protocol and reagents (FastTrack poly[A] 
RNA  isolation  kit;  Invitrogen).  To  remove  any  contaminating DNA, 
poly(A) RNA was incubated with DNAse (2 U in a total volume of 400/zl; 
Promega Biotec,  Madison, WI) at 37°C  for 30 min. The quality of each 
RNA preparation was assessed by fractionation through a denaturing aga- 
rose gel and staining in ethidium bromide. POly (A) RNA from 9-wk-old 
Sprague-Dawiey  rat muscle, heart, lung,  kidney, liver, and pancreas was 
purchased from Clontech (Palo Alto,  CA). 
RNA Isolation from Cultured Cells 
Neurons were  harvested from embryological  day  18 rat cortex cultures 
treated with Ara C (Magal et al., 1991). Approximately  95% of these cells 
have neuronal morphological  characteristics by phase microscopy following 
treatment with Ara C. Gliai cultures from postnatal day (PD) 2 rat cortex 
cultures were enriched for astrocytes  by differential attachment (Magal et 
ai., 1991). Astrocytes were harvested at either 50 % confluence or '~1 d after 
reaching 100%  confluence.  Cultured cells were  rinsed in ice cold PBS, 
dislodged by incubation at room temperature in 0.08 % trypsin in PBS, pel- 
leted, and stored at -70°C. 
PC12  cells (SPC12;  Schubert et al.,  1977) were grown in Dulbecco's 
modified Eagle's medium (with 3.7 g/l NaHCO3, 4.5 g/1 glucose,  0.584 g/l 
L-glutamine) containing 10%  fetal bovine serum, 5% horse serum, and 
penicillin-streptomycin  in  untreated  tissue  culture  flasks.  Cells  were 
propagated  from a  single  T-75 flask by splitting  1:2 after they  reached 
40-60% confluence. Control PC12 cells were harvested when they reached 
'~60%  confluence.  In other flasks,  when cells were  '~40%  confluent, 
differentiation was induced by changing to medium containing 2% fetal calf 
serum and 1% horse serum and adding/~-NGF to a final concentration of 
50 ng/mi. NGF was purified as described by Mobley et al. (1986) and kindly 
supplied by Dr. Mobley (University of California, San Francisco,  CA). Af- 
ter 1 d in the presence of NGF, ,v80% of the PC12 cells had processes ap- 
proximately one cell diameter in length. After 3 d NGF-treated  cultures 
were ,,,,60% confluent and ,~90% of the cells had processes two to five cell 
diameters in length. By 5 d, >90% of the cells had processes  greater than 
five cell diameters in length. Cells were collected at 1, 3, and 5 d after add- 
ing NGF and stored at -70°C. 
Swiss 3T3 fibroblasts  (American Type Culture Collection, Rockville, 
MD) were grown in the above Dulbecco's  modified  Eagle's medium with 
10% fetal bovine serum. One set of cells was harvested at 50% confluence 
and another approximately  1 d after reaching 100% confluence. 
Northern Hybridization 
Northern blot hybridization was carried out using standard protocols (Sam- 
brook et ai.,  1989). Poly(A)  RNA (2-4/~g) was electrophoresed  through 
a 1.3% agarose, 6.6% formaldehyde gel, and transferred overnight by capil- 
lary electrophoresis to a nylon membrane (Schleicher & Schuell,  Keene, 
NH).  Before and following transfer, gels were stained in ethidium bromide 
to assess RNA quality, degree of transfer, and location of RNA size markers 
(0.24-9.5 kb RNA ladder; GIBCO BRL, Gaithersborg, MD). To generate 
a probe corresponding to the LAR alternative 3' untranslated region, an 
'~0.9-kb AccI restriction fragment of pRLAR4.0 spanning from nucleotlde 
3098 of the insert (see Fig. 2 A, downstream from the CAG repeat region) 
to the AccI site in the vector multiple cloning site, was cloned into the AccI 
site of bluescript SK- (pLARAccI).  The orientation of the pLARAccI in- 
sert was confirmed by sequencing,  pLARAccI was linearized  upstream of 
the insert with DraII or XhoI enzymes and antisense riboprobe was gener- 
ated using T3 RNA polymerase and UTP[a-32P] (Promega Biotec reagents 
and transcription protocol). Oligonucleotide  probes were end-labeled with 
ATP[3,-32p] with T4 DNA polynucleotide  kinase (Sambrook et al.,  1989). 
Cyclophilin riboprobe was synthesized with SP6 RNA polymerase using rat 
cyclophilin clone plB15 linearized with PstI (Danieison et al., 1988). When 
using riboprobe,  blots were hybridized in buffer consisting of 5X SSPE, 5X 
Denhardt's, 50% formamide,  1% SDS, and 100/~g/ml salmon sperm DNA 
at 50°C overnight (Sambrook et ai., 1989). After hybridization,  blots were 
rinsed in 2X SSC/0,1% SDS three times for 5 rain each at room temperature, 
treated with RNaseA  (1 #g/ml; Promega Biotec)  in 2X SSC for 5 rain at 
room temperature,  washed in 0.IX SSC/0.1% SDS at 50°C for 30 rain, and 
then in 0.1X SSC/0.1% SDS at 65°C for 20 min. When using oligonucleotide 
probes, blots were hybridized in buffer consisting of 5X SSPE, 5X Den- 
hardt's,  1% SDS, and 10% dextran sulfate at 50°C overnight and were then 
washed in 2X SSC, 1% SDS buffer at 50°C for 30 min and 0.1X SSC, 1% 
SDS at 55°C for 30 min. Blots were exposed to x-ray film for 15 to 60 rain 
for cyclophilin detection and 1 to 4 d for LAR detection. 
RToPCR 
First strand cDNA synthesis with poly(A) RNA and random hexamers and 
subsequent PCR were conducted using reagents and protocols included in 
the GeneAmp RNA PCR kit (Perkin Elmer Cetus, Norwalk, CT). PCR was 
performed for 30 cycles as follows: denaturing,  94°C  1 rain; annealing, 
57°C  1 rain (68°C for primers flanking the CAG repeat region); extension, 
72°C 2 win. Primers are described in figure legends. All reverse transcrip- 
tion (RT)-PCR and PCR reaction sets included the use of water in place of 
template in one or more reactions as a negative control. Positive controls 
consisted of the relevant plasmids indicated in figure legends. RT-PCR prod- 
ucts were clectrophoresed  through 6% (10% for LASE-b) acrylamide gels, 
stained in ethidium bromide and photographed. Prominent and consistent 
bands of unexpected  size were extracted from agarose gels, subcloned into 
PCR vector (Invitrogen)  and sequenced  as described above. 
Quantitation of  RT-PCR 
The proportion of LAR transcripts with and withouta given insert or dele- 
tion was estimated by methods established for competitive  PCR, a tech- 
nique used for quantitative PCR or RT-PCR (Wang et al.,  1989; Gilliland 
et al., 1990; Foley et al., 1993). In competitive PCR or RT-PCR, templates 
differing by length (or other features such as restriction sites) but containing 
identical primer sites are coamplified in the same reaction.  Since amplifica- 
tion efficiency is primarily determined by primer sequences,  both templates 
are amplified  with a similar efficiency, even beyond the exponential  phase 
of the reaction.  The relative  amounts of final PCR product are therefore 
proportional to the starting proportions of the different  templates.  The 
proportionate quantities of each product can be readily determined by den- 
sitometric scanning of ethidium bromide-stained gels (Gilliland et al., 
1990). Coamplificatinn  with one set of primers of mRNA/cDNA isoforms 
differing by the presence of an insertion or deletion has proved useful for 
accurately quantitating changing proportions of mRNA isoforms (Small and 
Akeson,  1990). 
We used a similar strategy  for measuring the change in proportions of 
LAR isoforms. For each set of LAR RT-PCR products, the volume of prod- 
uct loaded onto gels and the amount of ethidium bromide staining were ad- 
justed so that the degree of band staining would be as close as possible to 
the midrange of band staining intensity. Band signals were quantitated by 
analyzing photograph negatives with a scanning densitometer.  The propor- 
tion of LAR transcripts with and without a given insert or deletion was esti- 
mated by calculating the ratio of band signal derived from RT-PCR product 
with a given insert or deletion over that without the insert or deletion. 
Significant differences in G/C content or secondary structure due to inserts 
or deletions could theoretically  cause differences in denaturation or poly- 
merase processivity and might thereby lead to an under-estimation in the 
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Therefore,  our data analysis focused on detecting any changes in propor- 
tions of LAR isoforms (i.e., during development) with and without a given 
insert or deletion rather than determining absolute proportions of isoforms. 
Southern Blot Hybridization of  RT-PCR Products 
PCR products derived with primers flanking LASE-b were electrophoresed 
in 10% aerylamide gels and transferred by nylon membranes (Hybond-N+; 
Amersham Corp., Arlington Heights, IL) by semidry electrotransfer.  Mem- 
branes were hybridized with a 32P-labeled 23 nucleotide antisense probe 
containing the 12 nueleotides  corresponding to the LASE-b insert and the 
11 nucleotides immediately downstream from LASE-b (Fig. 5). Hybridiza- 
tion was performed in a solution containing 1% SDS, 5X SSPE,  5X Den- 
hardt's,  and 10% dextran sulfate at 50"C overnight.  Blots were washed in 
2X SSC, 1.0% SDS  for 5  rain at room temperature and for 30 rain at 
50-55"C in the same solution. Filters were exposed to x-ray films 1 to 3 d 
at -70°C with an intensifying  screen. 
Generation of  LASE-a and LASE-c Antisera 
Peptides corresponding to LASE-a (GSSAPSCPNISS)  and LASE-c (CAQ- 
WRPEESEDYET)  regions were synthesized and conjugated  to KLH (key- 
hold limpet bemaeyanin).  Rabbits were immunized with conjugated peptide 
emulsified in Freund's complete adjuvant and boosting immunizations were 
emulsified in Freund's incomplete adjuvant.  Rabbits were boosted at 3-wk 
intervals and sera collected prior to immunization  and 11 d after each boost. 
Antibodies were purified by immunoaffinity  purification  using each of the 
above peptides coupled to a Sulfolink Gel (Immobilization Kit 2, reagents, 
and protocol; Pierce, Rockford,  IL). Antibodies were eluted with 100 mM 
glycine, pH 2.5 (Harlow  and Lane,  1988). 
Western Blot Analysis 
Western  analysis  was  conducted using standard protocols  (Harlow  and 
Lane,  1988) and the Western Exposure Chemiluminescent Detection Sys- 
tem (Clontech).  Protein extract was prepared from newborn rat cerebellum. 
Tissue was homogenized  in RIPA buffer for 30 min on ice, sonicated  for 
10 s, and centrifuged at 14,000 g for 20 rain. The supernatant was collected 
and concentrated using a Centricon-30 filter. Approximately  20 #g of pro- 
tein extract was electrophoresed  through a 6% acrylamide gel and trans- 
ferred to a nylon blot. LASE-a antiserum was also used to immunoprecipi- 
tate LAR from the above cerebellum extract.  100 #1 of supernntant was 
incubated with either 2  #1 of preimmune serum or  1 #1 of postimmune 
LASE-a antiserum for 2 h at 4"C. Antigen-antibody complexes were iso- 
lated  by  incubation with protein A-linked agarose  (Harlow  and  Lane, 
1988),  concentrated and electrophoresed.  Immunoblots were  incubated 
with  either  LASE-a  preimmune  serum,  LASE-a  postimmune  serum, 
affinity-purified LASE-a antibodies or affinity-purified LASE-c antibodies. 
Results 
The IntraceUular Domain of  LAR Is 
Alternatively Spliced 
To identify potential LAR isoforms, we screened an adult rat 
whole brain eDNA library for LAR eDNA clones using a 
30 nucleotide probe (nt2501-2530; see Fig. 3 A) correspond- 
ing to a site within the first tyrosine phosphatase domain of 
rat  LAR.  Clone  pRLAR4.0  contained  a  4-kb insert  with 
overlapping sequence identity to rat LAR starting ~45-bp 
downstream from the transmembrane domain and extending 
to a poly(A) tail (see Fig.  2).  The sequence of pRLAR4.0 
differed from that of constitutive rat LAR by two features. 
The first was the presence of a 33-bp insert (nt 80-112;  see 
Fig. 2 A) in the juxtamembrane region,  121-bp downstream 
from the transmembrane domain and 135-bp upstream from 
the  first tyrosine phosphatase domain.  We  name  this  in- 
sert LAR Alternatively Spliced Element-a (LASE-a).  The 
LASE-a  insert  maintained  the  open  reading  frame  and 
predicted  the  addition  of eleven  amino  acids,  SSAPSCP- 
Figure I.  Schematic summary of alternative LAR cDNA clones. 
Constitutive rat LAR (R/MR) is encoded by an '~8-kb transcript 
and contains 3 Ig-like domains (disulfide loops), 8 FN type III-like 
domains (hatched  boxes), a transmembrane domain (TM) and two 
protein tyrosine  phosphatase  (PTP-1 and PTP-2) domains (Pot et 
al., 1991; Yu et al.,  1992; Longo et al.,  1993). Clone pRLAR631 
was obtained from an adult rat hippocampus eDNA library and was 
identical to RLAR except for the absence of FNIII domains 4, 6, 
and 7 and the presence of a 33-bp insert (LASE-a) in the juxtamem- 
brane region and a 27-bp insert (LASE-c) in FNI~ domain 5. The 
insert of clone pRLARCB9 was derived by RT-PCR of adult rat 
cerebellum poly(A) RNA using a pair of primers corresponding to 
sites in FNIII domains 5 and 8. A 75-bp insert (LASE-d) was pres- 
ent between FNIII  domains 5 and 6. Clone pRLAR18.1 was isolated 
from an adult rat hippocampus eDNA library and in the juxtamem- 
brane region contained  LASE-a  and an additional  12-bp insert, 
LASE-b. Clone pRLAR4.0 was derived from an adult whole brain 
eDNA library.  This clone  had  an alternative  3' untranslated  se- 
quence (beginning at arrow indicating the divergence point) which 
included several runs of tandem CAG repeats (CAG). A transcript 
size of ~5 kb was estimated by Northern blot studies using a probe 
corresponding to the alternative 3' untranslated region (see Fig. 9). 
NISS.  Additional  LASE-a containing  cDNA  clones  were 
identified (Figs.  1 and 3).  The presence of introns flanking 
LASE-a (discussed below) demonstrated that LASE-a was a 
cassette exon (see Fig.  10). 
The second difference between pRLAR4.0 and constitu- 
tive rat LAR was the presence in pRLAR4.0 of an alternative 
3' untranslated sequence starting 240-bp downstream from 
LAR's stop codon and extending 1838 bp to a poly(A) tail 
(Figs.  1 and 2). This alternative 3' untranslated region con- 
tained  an  ,,o800-bp  GC-rich  segment consisting  of many 
CAG trinucleotide repeats.  The four longest uninterrupted 
stretches of tandem CAG repeats possessed 6, 7,  10, and 21 
uninterrupted repeats (Fig. 2 A, underlined).  Alignment of 
the  CAG repeat region  sequence  with itself revealed four 
"super-repeats" of 30-bp each in which 27 out of 30 nucleo- 
• tides were identical (Fig. 2 A, in boxes, B). Three of these 
30-bp repeats were continguous.  Two of the  four  longest 
uninterrupted  stretches of tandem CAG repeats (6  and  10 
repeats) were located partially or entirely within the super- 
repeats while the longest tandem CAG repeat was ,,o200-bp 
downstream from the cluster of 30-bp super-repeats. The al- 
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quence of LAR clone pRLAR4.0. (A) The in- 
sert  of clone  pRLAR4.0  starts  42-bp down- 
stream from the transmembrane domain of rat 
LAR. The sequence of pRLAR4.0 is identical 
to rat LAR except for the LASE-a 33-bp insert 
(boxed, top line) and an alternative 3' untrans- 
lated region (starting at bp 2104 shown in lower 
case,  arrow  indicates  the  divergent  point). 
Most of  the open reading frame is omitted from 
this figure (dots) and the  stop codon  is indi- 
cated by an asterisk.  Tandem CAG repeats of 
six or more in length are underlined.  Four 30- 
mer super-repeats in the 3' untranslated region 
are  boxed.  This  sequence  is  available  from 
GenBank/EMBL/DDBJ under accession num- 
ber X83505. (B) Alignment of the four 30-met 
super repeats. Sequence conserved across the 
four  super  repeats  other  than  CAG  repeats 
are boxed.  (C) RT-PCR was conducted  with 
primers flanking the 3' untranslated  divergent 
point (nt 2034-2053 and nt 2143-2162) which 
predicted a 129-bp product. PeR and RT-PCR 
were performed using the pRLAR4.0 plasmid 
as a positive control  and with poly(A)  RNA 
from the indicated tissues with (+) and without 
(-) reverse transcriptase  (left, ethidium bro- 
mide  stained  6%  polyacrylamide  gel).  The 
presence of the longest tandem CAG repeat (21 
repeats in clone pRLAR4.0) was demonstrated 
at the genomic  level by performing  PCR on 
genomic  DNA  isolated  from  five  rats  and 
primers flanking this repeat (nt 2872-2896 and 
nt 3012-3034) which predicted a 163-bp prod- 
uct. These primers generated product of  the ex- 
pected size when used for RT-PCR of the indi- 
cated cortex poly(A) RNA samples (P0, day of 
birth;  P21, 21-d postnatal;  Ad,  adult)  and  a 
similar sized product with pRLAR4.0 plasmid 
and genomic DNA samples (right, 6% poly- 
acrylamide gel). The band for rat 3 consistently electrophoresed slightly slower than the other four genomic products. (D) PeR products 
shown above in C were subcloned into pCR vector (Invitrogen) and five or six clones from each of the five rats (number of clones shown 
in parentheses) were sequenced to determine the number of CAG repeats; the number of repeats ranged from 17 to 24, the longest were 
found in PCR product derived from rat 3. 
ternative 3' untranslated region sequence had no significant 
matches with GenBank entries. 
RT-PCR was used to show that the 3' untranslated region 
alternative  sequence  in  clone  pRLAR4.0  was  present  in 
RNA transcripts in vivo and did not result from cloning ar- 
tifact. Using primers flanking the divergent point at which 
the alternative 3' untranslated region diverged from constitu- 
tive rat LAR (Fig. 2 A, arrow), RT-PCR with and without 
reverse transcriptase was performed. Products correspond- 
ing to the size predicted by pRLAR4.0 cDNA sequence fur- 
ther demonstrated that LAR transcripts containing the alter- 
native sequence existed in vivo (Fig. 2 C). RT-PCR product 
of the expected size was subcloned into pCR vector and se- 
quenced. Several clones had sequence identical to the region 
of pRLAR4.0 containing the divergent point.  The relative 
lack of RT-PCR product in the absence of RNA template and 
in the absence of reverse transcriptase indicated that LAR 
messenger RNA transcripts rather than contaminating DNA 
was amplified. 
The Longest Stretch of Uninterrupted CAG Repeats Is 
Polyrnorphic  in Length 
The length of tandem trinucleotide repeats in other genes is 
generally polymorphic. We attempted to determine if the en- 
"tire ,,o800-bp GC.rich region containing CAG repeats was 
polymorphic in length between five rats by performing PeR 
on genomic DNA. With a variety of PCR conditions using 
two different sets of primers each flanking this region, both 
sets of primers failed to generate product from either ge- 
nomic DNA or pRLAR4.0 plasmid itself. Difficulty in am- 
plifying extensive CAG repeats was also encountered with 
the Huntington's disease gene CAG repeat (Goldberg et al., 
1993). A third set of PeR primers flanking only the longest 
CAG repeat (21  repeats) did generate product of expected 
size  from pRLAR4.0  plasmid,  cDNA reverse transcribed 
from cortex poly(A) RNA and genomic DNA (Fig.  2  C). 
Using these primers, PCR product from rat 3  consistently 
electrophoresed at a slower rate than product from other rats 
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AGT~ACCCTGACATC,~CTC~TAC~CT~CTACGGCATC~AGTACC~AC~7/~ACAGA~GGCCCCTTCCA~~cA~ACCc~  120 
S  V  T  L  T  W  D  S  C  N  T  E  P  V  S  F  Y  G  I  Q  Y  R  A  A  G  T  P  G  P  F  Q  E  V  D  G  V  A  S  T 
TACAGCA~AOC~J'I'I-I'lCAC~J%TA~~CA~A~C.%~CCACCCA~(~OCAG'~:~C~A'C~A~A~C  240 
Y  S  I  G  S  L  S  P  F  S  E  Y  A  F  R  V  L  A  V  N  S  I  G  R  G  P  P  S  E  A  V  R  A  R  T  G~E  Q  A  P 
,.-  FN-2 
TCCAGCCCTCCACGCCGTG'TGCAGGCCCGAATGCTC.AC.CGCCAGCACCATC,  CTGGTACAGTGGGAA  CCC~C~CI~]~%C~%GCCC~a%~AC<}C~_~%TATCC~G~?~AC~7;ACACCCCA 360 
S  S  P  P  R  R  V  Q  A  R  M  L  S  A  S  T  M  L  V  Q  W  E  PL~  E  E  P  N  G  L  V  R  G  Y  R  V  Y  Y  T  P 
C~C*~CQ~C~C~C~2~AC~u%~AT~CAC~C4%~A(~C~%~ACCAC~G-l~A~AC~-~GGCA~A~ACA~CC~C~C~3Cg~AC~CC  480 
[9  $  R  R  P  L  S  A  W  H  K  H  N  T  D  A  G  L  L  T  T  V  G  S  L  L  P  G  I  T  Y  S  L  R  V  L  A  F  T  A 
FN-2  ,.~  ,--  FN-3 
~T  C~  GACGCCC~  CCA  GCCCCA  CCA  TCCAA  G'TCAA  GAC  AC.CA(2C~  C~ACA~CCTGCAGAC~CAGGCCAAAGCCGAG'fC(]GACACCAGC,  A'~AC~ATCAT~ 
VG  DG  P  P  S  P  T  I  QV  K~QQGV~L~A  O  P  A  P  FQA  K  A  E  S  DT  R  I  O  L  S  W  b  600 
CTGCCCC~GCAC~C~TCATCAAGTATGACC~ACTGGGCAGCAGA~ATCAAGGCCAGCAGCAC~GA~C~A~ACA~~G  720 
b  P  P  Q  E  R  I  I  K  Y  E  L  V  Y  W  A  A  E  D  E  G  Q  Q  H  K  V  T  F  D  P  T  S  S  Y  T  L  E  D  L  K 
FN-3  FN-5 
CC~CACACTGTACCACTTCCAGCTGG~AGAT'~ACTCCCACCG'TAGAGCC~AC  ACAGTCC  CTA  CACCACGC.AAGGTG 840 
P  D  T  L  ?  H  F  Q  L  A  A  ~  S  P  U  G  V  G  V  F  T  P  T  V  ~  A  ~  ~V A  Q  s ~{~IS~P  ~P  $  O  P  ~  s  K  V 
GAGG'TTGAGCCTCTGAACTCCACT~GCATGTCTCCTC~2-AAGCTGCCCGTCCCCAACAAGCAGCA  C~CA~A~A~CA~AT~~G  960 
S  V  E  P  L  N  $  T  A  V  H  V  S  W  K  L  P  V  P  N  K  Q  H  G  Q  z  R  G  Y  Q  v  T  ¥  V  ~  U  £  ~  G  E 
CCCCC-AG(~CCAC=CCCATCATCCAC~T~ATC~GAC~A~  ~CCACCATCA(3CA~ACCCCCC.AGACCACCTACTCCATT  1080 
P  R  G  Q  P  I  I  Q  D  V  M  L  A  E  A  Q  •  T  T  ~  S  S  L  T  P  E  T  T  Y  S  I 
--FN-8  ~CA~Cro~  AC~  C~AC  ACC  A  CTAA  GC~  TC~  C~GC  AA  C,  CCCA~ G'T~  A  CTAC  CA  C  CA2&C~T'~CG~AATC~  1200 
FN-5  del 2~  '--- 
CTCCTCAGTTGGCAGGTCCCCGACTCTTACAAGTCAGCTGTACCCTTCAAGATCCTGTACAATGGGCAGA~T~  A~CCA~  ~A~C~  1320 
L  L  S  W  E  V  P  D  S  Y  K  S  A  V  P  F  K  I  L  Y  N  G  Q  S  V  E  V  D  G  H  S  M  R  K  5  I  A  D  L  Q 
CCCAACA~AGAGTACTCCTTCGTCCTGATGAA~C~AGCAGCGCTGGGGGCCTA~AGCACCTGGT~CC~A~CCA~CA~A~  1440 
P  N  T  E  Y  S  F  V  L  M  N  R  G  S  S  A  G  G  L  Q  H  L  V  8  1  R  TIA  P  D  L  L  P  Q  K  P  D  P  A  S 
GCCTTTATAGAGGA  CCTCTCCATGCCTCAAGTGCAGGACCCCTCGL~TAGTCAGGT~CTACATT~ATTGACCGTGTGGGC~A  1560 
A  F  I  E  D  G  R  F  S  L  S  M  P  Q  V  Q  D  P  S  L  V  ~  W  F  Y  1  V  V  V  P  I  D  R  V  G  G  N  L  L  A 
CCAAGA  TGGAGCACACCAGAGGAGCT~C~CGAC~CTC~GGCCATCGAGCAC~CA~~A~~AC~A  1680 
P  R  W  S  T  P  E  E  L  E  L  D  E  L  L  E  A  I  E  Q  G  E  E  K  Q  R  R  R  R  R  Q  A  ~  R  L  K  P  Y  V  k 
GCTCAA~CGAGCTCCCTGACACCTI~AC~CAAGAAGAAC~AC~ACAACCC~-~`CC~TCTGAGTTAcCA~C-~CTCCL.`TC  1800 
A  Q  V  D  E  L  P  E  T  F  T  L  G  D  K  K  N  Y  R  G  F  Y  N  R  P  L  S  8  D  L  S  Y  Q  C  F  V  L  A  $  L 
AAC~AACCCATGGACCAGAAC~C~CTAT<k~TCCAGCCCCTAC~fCC~3ACC-%GATCGTAGTCCACGTCACACCAGCCCA~A~A~~CA~C~  ~920 
K  e  P  M  O  Q  K  R  g  A  S  S  P  Y  S  D  E  I  V  V  O  V  T  P  A  Q  Q  Q  E  E  P  ~  ['I  L  W  V  T  ~  p  %/ 
C~AGTCATTCTCATCATACTCATTG`TCATCGCTATCCTCCTATTCAAGAGGAAGAGAACACATTCCCCATCGTCAAA~A~A~~~  2040 
L  A  V  ~  L  I  I  U  I  V  [  A  I  L  U  F  K  R  K  R  T  H  S  ~  S  S  K  P  E  Q  S  1  G  L  K  D  S  L  L  A 
CACTC~CCCT~TGCGAAC~AACTACCAGACCCCAC~  ~%~T;~A  ATC2CGAGACCACCCC~ATCCCCATCACTC,  ACCTG 2160 
..........  L  N  Y  Q  T  P  ~'~'1..  ,  ,  •  c  ~'  g  I  ~1  lr]  ............ 
GCAGACAATATTGAACGTC~AAAC~CCAATGATGGGCTCAAGTTCTCCCAGGAGTATGAGTCCATTGACCC~CAGCAG~A~~A~C~  2280 
A  D  N  I  E  R  L  g  A  N  ~  G  L  K  F  S  Q  E  Y  E  S  I  D  F  G  Q  Q  F  T  W  E  N  ~  N  S  E  %/  N  K  P 
AAGAACCGCTATGCAAACGTCATTGCCTATGACCACT~GTCC.1`CCTCACCTCCATTC~ATGGT~cTGGGAGTGA~ACA~ACA~AC~AG  2400 
g  N  R  ¥  A  M  V  I  A  ?  D  H  S  g  V  L  L  T  ~  [  D  C  V  P  C  S  D  %"  I  N  A  N  ~  T  D  C.  %'  R  R  (% 
AA~`~C~pACATC~CACACAC~`~"r;~C-~C~%C"~CCA~I-lL~F(~C~%~G~G~CAC~ACAC42CACAG~]~G~CA~`&%~-4~A~AC~%(~C4%~CL.~aG  2520 
N  A  Y  I  A  T  O  G  P  L  P  E  T  M  G  D  F  W  R  M  V  W  E  O  R  T  A  T  V  V  M  M  T  R  L  E  E  K  S  R 
GTC,AAG~TGT~TCAGTATTC~AGCCCGTGGCACTC~GACCTATGGCCTCATTcAGGTGACL~CACT~AC~ACA~A~A~A~AT~  2640 
V  K  C  D  O  Y  W  P  A  R  G  T  ~  T  Y  G  I.  I  O  V  T  L  V  r3  T  V  ~  L  A  T  Y  '11  M  R  T  ~  A  L  N  M 
AC.CGG~CAGTGAGAAGCGTGAG~AGTTCCAGTTCA  TGGCCTGGCCAGACCATC~CTC~ACC~A~A~~~C  2760 
S  G  s  s  E  K  R  E  L  R  O  ~  O  ~  S  A  W  P  P  H  G  V  ~  ~  Y  P  T  P  I  L  A  F  L  R  ;~  V  W  A  C  N 
CC~AGATGCAGGACCCATGGTGGTGCA~i~AGTC~ACGGGCTGCTTCATTGTCATCGACGCAATGCTC~GCGTA~A~CA~A~AT  2880 
L  D  A  C  P  M  V  V  }4  C  S  A  n  ~  G  R  'T  C  C  F  I  V  ~  [~  A  M  [,  R  R  M  M  )4  ~  R  T  V  D  I  V 
GGCCACGTC~ACGTGCATGCGCTCACAAAGGAACTACATGG~AGACAGAGGACCAGTATGTGTTCATCCACGAGGCACTGTTA~CAT~CACA~  3000 
C  ~  V  T  C  H  R  S  O  a  ~  Y  H  V  O  T  ~  D  O  V  V  F  ~  ~  E  k  L  L  ~  k  A  H  C  ~  14  T  ~  V  L  A 
C~CCF~A~CCACA~CAG~A~AAG~`~L~2C~A~CA1~3C~%C~.~r~C4%~)%%~C~C~I~C~(~,~CAcACG`~-~I~2~Aq~f  1120 
R  N  L  g  A  H  I  O  K  L  G  Q  v  p  P  G  E  S  v  T  k  M  g  L  g  F  K  L  L  A  N  S  K  A  H  T  S  R  F  I 
AG'TC.CCAACC~AACAAGTTCAAGAACC~GG~CATCATGCCCTATC.AGCTGACTCGAGT~C~A~~ACA~C  3240 
S  A  S  L  P  C  S  K  P  K  N  R  L  %2  N  T  M  P  Y  ~  I,  T  ~  %'  c  L  o  p  I  R  c  v  R  c.  s  D  v  ~  N  A 
A~AC"~ACACJ~CA(~2AG~C~ACATA(~C~ACACA~C~GCACCC~%C~4~A~-~FA~C~-4~GCA~AA~CAC~CA~ATCG~CA~  3360 
F  L  ~  ~  V  R  O  o  r  k  v  T  ~  T  O  G  P  h  A  ~  s  ¢  ~  D  ~  w  ~  ~  L  W  E  H  N  ,5  T  ;  I  v  s 
CTGACC~AAGCTTC~GATC~AC~GAAAT~ACCAGTACT~C,  CAGAGCGC~ATCAATA~C~AC~CA~A~AT  3480 
L  T  K  I,  R  E  M  G  R  ~  K  C  H  O  Y  W  P  A  E  R  S  A  R  Y  O  Y  ~  V  V  D  P  M  A  R  Y  N  M  P  O  Y 
ATCC~GTGAA~fCAAAGTCACAGATGCCCcGGATGGGCAGTCAAGGACAATCCGACAGTTCCAGTTTA~AGAc~AGA~A~C~A~  3600 
I  L  R  R  F  K  V  T  D  A  R  D  ~  e  S  R  T  I  R  O  p"  O  F  T  D  W  P  R  O  C  V  P  K  T  ~  R  C.  F  I  D 
TTCATCGGGCAGGTGCACAAGACAAAGGAGCAGTTTGGACAC`GATGGGCCCATCACAGTACACTGCAGTGCTGG~CGCACAGGGG~AT~ACCL~A~G  3720 
F  I  G  O  V  H  K  T  I(  ~  O  ~  G  O  D  a  ~'  I  T  V  ~  c  ~  A  G  V  n  R  T  ~  Y  F  l  'r  t  S  ~  V  I,  ~: 
CGCATGCGGTACGAGC~GTC~CATGTTCCAGACCGTGAAGACCC~CGCACACAGCC~CT~AAT~A~A~TACCA~A~Z~  3840 
s  R  V  E  a  V  V  n  ~  ~  O  T  V  K  T  L  R  T  O  n  P  k  M  V  O  T  g  n  e  V  O  L  C  V  R  k  A  I. 
TAC~C~A~AC~A~C~CG~fAA~A~C~f~C~`~C(~C~CCL`~]~?~<~C~aC~:~C~C~`~C~%L~ACaC`~C~`]~AC<2~ATAC~A~C~A~C  3960 
Y  L  C  S  ~  n  S  Y  A  T  * 
TCC~A~GGATC~CGGCAGAGCA~AGCCCACTC~TCACAC,CATTTCC~CATTGCCA~ACCAGTCAGAC~GCCCA~CA~A~A~G  4080 
C~:-~Cy~CCL~I~G~CACc~C~2~G~(~C~%GCCC~pGC~~A(~C`]~C~%~cA~(~(~G~CAC~A(~C~C~-~C~ATAC  4200 
ATTTAG~AGACT~AGCCTCTT~CC.ACTTT~AG~ACTACAGA~GTA~CTTA  .GTTC 43~0 
ACGTTGGATCC~ACAAC~GGACACAG~ACACC,  C~CTCGAGCAGACaCTAG~CTACCTCaAGCAA~~A~  4440 
T~CTCCAGCCT~AGAGGAGATCCTA~'I'CCAGCCAAATC~CAGGGAAACACTTTAT~AC~q  l'l'l  Ix2CTTGAGAGCL-I-I-I-t-I-F/'AGOCCCCACAGACAGTGGT~  4560 
GGGGAGGCGATAGGA~CACATCCCCAGTGTGCA'~AACATTCATAGCCTA  C~.~eCACAGACGT~GCCTC~AAC~CTCGTCA~A~~C  4680 
AAAA  4685 
B  pRLARCB9 
FN-5 ~  •  _ 
TCCACCTACTCCATTACI~CTACACCACTAAGGGGGATC~CCGAACCAAGCCCAAAG'TC~ACTACCAC  A  120 
pm.~l~  CB9  S  T  Y  S  I  T  V  A  A  Y  T  T  K  G  D  G  A  I~  S  K  P  K  V  V  T  T  T  G  A  O  II  •  Q  V  It  D  *  A  G  W 
RATLAR  S  T  Y  S  I  T  V  A  A  Y  T  T  K  G  D  G  A  R  S  K  P  K  V  v  T  T 
t--  FN-6 
p~R  CB8  &  A  G  1  A  &  P  |  P  J  &  ¢  C  B  G  8  P  T  M  M  V  S  T  T  A  H  H  T  A  L  L  Q  W  H  P  P  K  E 
BT[.~  G  8  P  T  M  M  V  $  T  T  A  M  H  T  A  L  L  Q  W  H  P  P  K  E 
C  pRLAR18.1 
•  ATGCT~GACAGGCCCTGTCCTGGCAG'FCATTCTCATCATACTCATTCTCATCGCTATCCTCCTATTCAA  ~G~CACA~CCCATCGTC~C~T 
•  • •  M  L  W  V  T  G  I@  V  L  A  V  i  L  I  I  L  I  V  I  A  I  L  L  F  ~C~~  R  T  H  S  P  S  S  K  D 
G~rC~CA~C~TCCP~.~C-F~C~%~CCC~G~CCCA~CC~T~C~t~ACCA~CCCCA  ~A~I'L-"T(= 
v  Q  S  ;  g  U  K  D  S  L  L  A  H  S  S  ~  P  V  E  M  ~  R  L  N  Y  Q  T  P~  I  s 
Figure  3.  Nucleotide  and  pre- 
dicted amino acid sequence of al- 
ternative  RLAR  cDNA  clones. 
(A)  The  sequence  of the  clone 
pRLAR631  insert  begins  12- 
amino acid downstream from the 
start of FNIII domain 1. Overlap- 
ping sequence of done pRLAR631 
was identical  to that of rat LAR 
except  for  the  following:  (a) 
FNIII  domains 4, 6, and 7 were 
absent; (b) a 27-bp insert (LASE- 
c) was present in FNIII domain 5 
(boxed);  (c)  the  LASE-a  33-bp 
insert  was  present  in  the  jux- 
tamembrane region (boxed); and 
(d) the 3' untranslated  region ter- 
minated just prior to the poly(A) 
tail. FNIII domains (Patthy, 1990) 
are  indicated  by  brackets  and 
arrows  indicate  sites  of deleted 
FNllI-like domains 4 (deletion 1) 
and 6-7  (deletion 2).  The trans- 
membrane domain is indicated by 
the  heavy  underline,  tyrosine 
phosphatase domains are under- 
lined and the stop codon is marked 
by  an asterisk. This sequence is 
available  from GenBank/EMBL/ 
DDBJ  under  accession  number 
X83505.  (B)  pRLARCB9  was 
derived by RT-PCR of adult cere- 
bellum poly(A)  RNA  using pri- 
mers  corresponding  to  sites  in 
FNIII domains 5 and 8 (nt 1068- 
1089 and nt 1196-1217; in A). The 
sequence of this RT-PCR product 
(only the first 240 bp are shown) 
was identical to rat LAR (FNIU 
domains 5 to 8) except for a 75-bp 
insert  (LASE-d,  boxed)  located 
between FNIII domains 5  and 6 
which  contained  two  in-frame 
stop  codons  (asterisks).  (C) 
Clone pRLAR18.1  contained  an 
LAR insert extending from within 
FNIII domain  8  (nt  1313  in A 
above) to near the 3' end of the 
LASE-a insert. The 3' end of this 
insert (shown here) contains the 
12-bp LASE-b and 33-bp LASE-a 
inserts  (boxed); the  transmem- 
brane region is underlined. 
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tions. Subclonlng and sequencing of PCR products showed 
polymorphism of the  CAG repeat  number and that PCR 
product from rat 3 contained one to three additional repeats 
compared to the other rats (Fig. 2 D). PCR product from rats 
2 and 5 contained four different repeat lengths. Only two 
alleles from each rat would be expected; therefore, these 
results suggested that CAG repeats can also expand or con- 
tract during PCR amplification  or during plasmid replication 
in bacteria. Repeat PCR determinations of the Huntington's 
disease CAG repeat have demonstrated small variations in 
non-expanded alleles (11-37 repeats) of up to two repeats and 
a standard deviation of less than one repeat (Andrew et al., 
1993). Variations in repeat number during bacterial cloning 
have not been described.  Our  findings that PCR product 
from rat 3 was of slightly greater length suggested that rat 
LAR CAG repeats have at least a small degree of polymor- 
phism within an inbred rat strain. 
Identification of a Third Site of lntraceUular 
Alternative Splicing 
We searched for additional LASE-a containing LAR rnRNA 
isoforms by screening an adult rat hippocampus eDNA li- 
brary using an oligonucleotide corresponding to the LASE-a 
region.  One LASE-a containing LAR clone (pRLARI  8.1; 
Figs.  1 and 3 C) had an additional insert, termed LASE-b, 
which started 5-bp downstream from the transmembrane do- 
main, interrupted the AGG codon (arg) and maintained the 
open reading frame. LASE-b predicted the insertion of the 
amino  acids  SKQE  starting one  amino acid downstream 
from the transmembrane domain followed by the reconstitu- 
tion of the AGG codon. Cloning and sequencing flanking in- 
trons demonstrated that LASE-b was also a cassette exon 
(see Fig.  10). 
LAR ExtraceUular Domains Are Alternatively Spliced 
Screening the adult rat hippocampus library with the LASE-a 
probe also led to the isolation of an unexpected LAR clone 
which  suggested extensive alternative splicing of the  ex- 
tracellular domain. Clone pRLAR631 (Figs.  1 and 3 A) con- 
tained a 4.7-kb insert with sequence identical to constitutive 
rat LAR except that FNIII domains 4, 6, and 7 were deleted, 
a 27-bp insert was present within FN1TI domain 5 and LASE-a 
was present in the juxtamembrane region. The 27-bp insert, 
LASE-c, maintained the open reading frame and encoded 
the nine amino acid sequence WRPEESEDY. PCR using ge- 
nomic DNA with two pairs of primers, each pair flanking 
one of the LASE-c splice junctions, suggested that LASE-c 
was flanked by introns and was therefore also an alternatively 
spliced cassette exon. In summary, screening of two eDNA 
libraries resulted in the isolation of 25 distinct LAR clones. 
LAR Intracellular Domain Alternative Splicing Is 
Highly Regulated 
RT-PCR using primers flanking sites of alternative splicing 
has proven to be an accurate technique for quantitative anal- 
ysis of alternative splicing (see Materials and Methods). RT- 
PCR using primers  flanking LASE-a was  used to detect 
changes in the proportions of LAR transcripts containing 
LASE-a (Fig. 4). The proportion of LAR transcripts mea- 
sured at each time point containing LASE-a significantly  de- 
creased during cortex development (P < .05, analysis of vari- 
ance;  ANOVA) and cerebellar  development (P  <  .0001, 
ANOVA). After sciatic nerve transection, the proportion of 
LAR transcripts with LASE-a increased by 45 % (P <  .05, 
two-tailed t-test)  in the nerve segment distal to the transec- 
tion and increased by 30%  in denervated muscle (without 
statistical  significance).  LASE-a  was  preferentially  ex- 
pressed  in cortex,  cerebellum,  skeletal muscle and heart 
compared to six peripheral organs. The presence of LASE-a 
signal in human testes RNA demonstrated that LASE-a was 
also present in human as well as rat tissue. Interestingly, 
using this same pair of  primers flanking LASE-a, PCR failed 
to amplify poly(A) RNA derived from mouse 3T3  fibro- 
blasts. PC12 cell differentiation induced by NGF led to an 
'~50%  decrease in the proportion of LASE-a containing 
LAR transcripts (P <  .05, ANOVA). 
RT-PCR with primers flanking LASE-b also demonstrated 
regulation of the proportion of LAR transcripts containing 
LASE-b (Fig. 5). Only a very small proportion of LAR tran- 
scripts contained LASE-b; bands containing LASE-b were 
not visible, unlike LASE-a containing bands, in ethidium- 
stained gels. To detect LASE-b we transferred RT-PCR prod- 
uct to nylon blots which were probed with a 32P-labeled oli- 
gonucleotide. An oligonucleotide was designed which would 
preferentially hybridize to LASE-b containing PCR product 
to allow the  simultaneous detection of product with and 
without LASE-b (Fig. 5).  The relative proportion of LAR 
transcripts with LASE-b measured at each time point in- 
creased during development: a sixfold increase in the cortex 
from P0 to adult (P <  .05, two-tailed t test) and a threefold 
increase (without statistical significance) in the cerebellum 
during the same time period. NGF-induced differentiation of 
PC12 cells caused a threefold increase (P <  .05, two-tailed 
t-test)  in the relative proportion of LAR transcripts with 
LASE-b. This proportion decreased by approximately seven- 
fold (P <  .0005, two tailed t-test)  in 3T3 fibroblasts by one 
day after reaching 100% confluence. LASE-b was preferen- 
tially expressed in brain LAR transcripts compared to tran- 
scripts in muscle and six peripheral organs. No LASE-b sig- 
nal was detected in cultured astrocytes and only very faint 
signal was detected in cultured embryonic neurons.  This 
faint signal  was  consistent with the  observation that the 
proportion of LASE-b containing transcripts increased dur- 
ing development. 
LAR Extracellular Domain Alternative Splicing Is 
Highly Regulated 
Regulation of LASE-c splicing was studied with RT-PCR 
using primers  corresponding  to  sites  in  FNIII domain 5 
flanking LASE-c (Fig. 6). The relative proportion of LAR 
transcripts containing LASE-c decreased during develop- 
ment by ~60% in the cortex (P <  .05, ANOVA), by 90% in 
the cerebellum (P <  .0001, ANOVA), and by 50 % in the spi- 
nal cord (P <  .0001, ANOVA). LASE-c was not detected in 
normal or transected sciatic nerve. LASE-c was barely de- 
tectable in normal muscle but increased by '~ll-fold after 2 
wk  of denervation  (P  <  .0001, two  tailed  t-test).  NGF- 
induced differentiation of PC12 cells caused an eightfold (P 
<  .005, ANOVA) increase in the proportion of LASE-c con- 
taining transcripts.  This proportion also increased by ap- 
proximately 20-fold (P <  .0001, two-tailed t-test)  in fibro- 
blast upon reaching confluence. LASE-c was preferentially 
Zhang and Longo Regulation of LAR Alternative Splicing  421 Figure 4. Regulation of LASE-a splicing. RT-PCR  was performed using primers flanking LASE-a (nt 2011-2030 and nt 2201-2218, Fig. 
3 A, predicting 175- and 208-bp products) with poly(A) RNA from the indicated tissues and cells, pRLAR4.0 plasmid DNA, containing 
the LASE-a 33-bp insert, was used as a control. Cortex (CTX) and cerebellum (CB) poly(A) RNA were obtained from three developmental 
time points (P0, day of birth; P21, 21-d postnatal; Ad, adult). All tissues in the middle panel were from adult rats except for testes RNA 
(adult human). RNA was analyzed from control proliferating PC12 cells (Cont.) and differentiated PC12 cells following 3 and 5 d of NGF 
treatment (Materials and Methods). RNA from normal sciatic nerve (NL nerve) and normal gastrocnemious muscle (NL muscle) was com- 
pared to RNA isolated from the distal nerve segment (Nerve-denerv.; 2 wk) and denervated gastrocnemious (Muscle-denerv.; 2 wk) 2-wk 
postsciatic nerve transection. Products were electrophoresed in 6 % polyacrylamide gels, stained with ethidium bromide and photographed. 
Photograph  negatives were analyzed by scanning densitometry  and the ratio of the signal from the upper band (with LASE-a) over the 
signal from the lower band (without LASE-a) was calculated. The mean ratio + SE from separate RT-PCR reactions (number of reactions 
indicated in parentheses)  is shown. 
expressed in brain and spinal cord compared to nerve, nor- 
mal muscle and six other peripheral organs.  LASE-c was 
abundant in cultured neurons but not detected in cultured as- 
trocytes. 
Deletion of FNIII domain 4  was analyzed with primers 
corresponding to sites in FNIH domains 3 and 5  (Fig.  7). 
Significant  developmental  regulation  of  FNIII  domain  4 
splicing was found only in cerebellum in which there was a 
2.5-fold decrease (P <  .001, ANOVA) in the relative propor- 
tion of LAR transcripts missing this domain. Transection of 
sciatic nerve caused a  fivefold increase (P <  .05, ANOVA) 
in this proportion at one and two weeks posttransection in 
the distal nerve segment and an approximate 13-fold increase 
(P <  .0005, two-tailed t-test) in muscle at 2-wk posttransec- 
tion. PC12 cell differentiation was associated with a 50% in- 
crease (P <  .05,  ANOVA) in the proportion of transcripts 
missing FNIII domain 4. This proportion increased 4.5-fold 
(without reaching statistical significance) in 3T3 fibroblasts 
upon reaching confluence. Deletion of FNIII domain 4 pref- 
erentially  occurred  in  brain and  spinal cord compared to 
muscle and six other peripheral organs and was evident in 
cultured neurons but not detected in cultured astrocytes. 
Deletion of FNIII domains 6-7 was assessed with primers 
corresponding to sites in FNIII domains 5 and 8  (Fig.  8). 
The relative proportion of LAR transcripts missing the 6-7 
domains decreased by 60 % during cerebellar development 
(P <  .005, ANOVA) and by 45 % during spinal cord develop- 
ment  (P  <  .005,  ANOVA).  Transection  of sciatic  nerve 
caused a  small (,,o28%) but significant (P <  .05,  ANOVA) 
decrease in the proportion of transcripts with this deletion 
in the distal nerve trunk and a marked increase from unde- 
tectable levels in denervated muscle. Differentiation of PC12 
cells induced a 4.3-fold increase in the proportion of tran- 
scripts with the 6-7 deletion (P <  .01, ANOVA) and fibroblast 
confluence  caused  a  2.5-fold  increase  (without  reaching 
statistical  significance).  The  FNIII  domain  6-7  deletion 
selectively occurred in brain, spinal cord and nerve and was 
not detected in muscle or the six other peripheral organs. 
The Journal of Cell Biology, Volume 128, 1995  422 Figure 5. Regulation of LASE-b splicing. RT-PCR  was performed with primers flanking LASE-b (nt 1913-1932 and nt 2033-2052,  Fig. 
3 A, predicting  140- and 152-bp products) with poly(A) RNA from the indicated tissues and ceils. Plasrnids pSKb4.14 and pSKb3.8 are 
cDNA clones with (upper band) and without (lower band) the 12-bp LASE-b insert,  respectively, and were used as controls.  Neuronal 
poly(A) RNA was derived from cultured El7 rat cortex neurons and astrocyte poly(A) RNA was derived from astrocyte cultures (at either 
50 or 100% confluence) prepared from 2-d postnatal rat cortex. PC12 cells were differentiated with NGF for 3 d.  Swiss 3T3 fibroblasts 
(FB) were harvested at either 50% confluence or 1 d after reaching 100% confluence. Since the upper band was not visible on ethidium 
stained polyacrylamide gels, bands were transferred to a nylon blot and probed with a 32P-labeled 23-nucleotide probe corresponding to 
the 12 LASE-b nucleotides and the 11 adjacent downstream nucleotides. Blots were washed and then exposed to film for 2-3 d and band 
intensity measured by scanning densitometry. The ratio of signal from upper bands (with LASE-b) over the signal from the lower bands 
(without LASE-b) was calculated.  The mean ratio  +  SE from separate RT-PCR reactions (number of reactions indicated in parentheses) 
is shown. 
This deletion was present in cultured neurons but either not 
detected or barely detected in astrocytes. 
RT-PCR analysis of FNM domains 6-7 splicing unexpect- 
edly demonstrated a band slightly larger than that predicted 
for constitutive rat LAR (Fig. 8 A, cerebellum, spinal cord, 
muscle, and heart). Subcloning and sequencing of this prod- 
uct derived from adult cerebellum poly(A) RNA revealed a 
75-bp insert, LASE-d (Fig. 3 C), located between FNIII do- 
mains  5  and  6.  This  insert  contained  two  in-frame  stop 
codons and therefore constituted a retained intron (Smith et 
al.,  1989). The identical LASE-d sequence was found using 
the same PCR primers with heart poly(A) RNA.  This in- 
dependently  derived  sequence  demonstrated  that  the  stop 
codons  did  not  result  from  either  Taq  polymerase DNA 
replication or sequencing errors. Transcripts containing the 
LASE-d retained intron would lead to premature termination 
of protein translation prior to the transmembrane domain; 
therefore, the presence of LASE-d suggested the possibility 
of a  secreted LAR isoform. 
The  relative  proportions  of  LAR  transcripts  retaining 
LASE-d  were also  examined  (Fig.  8).  The  proportion  of 
LASE-d containing  transcripts increased by 4.5-fold (P < 
.05,  ANOVA)  in  the  cerebellum  and  twofold  (P  <  .05, 
ANOVA)  in the  spinal cord during development.  LASE-d 
was  not  detected  in  normal  or  transfected  nerve and  de- 
creased  by 50%  (P  <  .05,  two-tailed  t-test)  with  muscle 
denervation.  LASE-d  was not  detected  in proliferating or 
differentiated  PC12  cells.  Fibroblasts  reaching  confluence 
led to a 40% decrease in the proportion of LASE-d contain- 
ing transcripts (P <  .05,  two-tailed t-test).  LASE-d was ei- 
ther not detected or barely detected in cultured embryonic 
neurons and astrocytes. 
Northern Analysis Predicts a Developmentally 
Regulated,  Markedly Truncated LAR Isoform 
Previous Northern  blot hybridization analysis of rat LAR 
had suggested the presence of LAR mRNA isoforms shorter 
than the  "o8-kb form including  bands  at  ,o7  kb and faint 
bands at ,o5 kb (Longo et al., 1993). We used Northern blot 
Zhang and Longo Regulation of LAR Alternative Splicing  423 Figure 6. Regulation of LASE-c splicing. RT-PCR was performed with primers flanking LASE-c (nt 937-955 and nt 1081-1098, Fig. 3 A, 
predicting 135- and 162-bp products) with poly(A) RNA from the indicated tissues and cells. Plasmid pRLAR631 which contains LASE-c 
was used as a control. Labels for tissues and ceils are as defined in previous figures (SC, spinal cord). RNA from normal sciatic nerve 
(NL nerve) and normal gastrocnemious muscle (NL muscle) was compared to RNA isolated from the distal nerve segment (trans. nerve) 
and denervated gastroenemious (den. muscle) 2-wk postsciatic nerve transection. RT-PCR products were electrophoresed in 6% polyacryl- 
amide gels, stained with ethidium bromide and photographed. Photograph negatives were analyzed by scanning densitometry and the ratio 
of the signal from the upper band (with LASE-c) over the signal from the lower band (without LASE-c) was calculated. The mean ratio 
+  SE from separate RT-PCR  reactions (number of reactions indicated in parentheses) is shown. 
Figure 7. Regulation of FNIII  domain 4 splicing. RT-PCR was performed with primers flanking FNIII domain 5 (nt 746-765 and nt 866-886, 
Fig. 3 A) with poly(A) RNA from the indicated tissues and cells, cDNA sequence predicted products of 141  (FNll-I domain 4 deleted) 
and 445 bp (FNIH domain present). Plasmid pRLAR631 in which FNIII domain 4  is deleted was used as a control. Labels for tissues 
and cells are as defined in previous figures. RT-PCR products were electrophoresed in 6%  polyacrylamide gels, stained with ethidium 
bromide and photographed. Photograph negatives were analyzed by scanning densitometry and the ratio of the signal from the lower band 
(without FNIII domain 4) over the signal from the upper band (with FNIII domain 4) was calculated. The mean ratio +  SE from separate 
RT-PCR  reactions (number of reactions indicated in parentheses)is shown. 
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Figure 8.  Regulation of FNIII domains 6-7 and LASE-d splicing.  RT-PCR was performed with primers corresponding to sites in FNIH 
domains 5 and 8 (nt 1067-1088  and nt 1196-1217,  Fig. 3 A) with poly(A) RNA from the indicated tissues and cells, eDNA sequence predicted 
products of 151 bp (FNIII domains 6-7 deleted) and 732 bp (FNIII domains 6-7 present).  Plasmid pRLARfi31  in which FNm domains 
6-7 are deleted was used as a control. Labels for tissues and ceils are as defined in previous figures. RT-PCR products were electrophoresed 
in 6%  polyaerylamide gels,  stained with ethidium bromide,  and photographed.  Two unexpected prominent bands were also present;  a 
band slightly above the 732-bp band and a band slightly below the  151-bp band.  PCR product from these unexpected bands and the two 
expected bands was isolated, subcloned into pCR vector (Invitrogen) and sequenced. The upper band contained the LASE-d 75-bp insert 
(clone pRLAR CB9 as described in Fig.  3). The lower band sequence had no identity to LAR, consistent with non-specific priming. The 
two expected bands contained the predicted LAR sequence.  Photograph negatives were analyzed by scanning densitometry and the ratio 
of signal from the expected lower band (without FNIII domains 6-7) over the 732-bp band (with FNIII domains 6-7) was calculated. The 
ratio of signal from the uppermost band (with LASE-d) over the signal from the 732-bp band (with FNIII domains 6-7) was also calculated. 
The mean ratio  +  SE from separate RT-PCR  reactions (number of reactions indicated in parentheses) is shown. 
analysis to determine which transcripts contained the alter- 
native  3' untranslated  region.  Northern  blots probed  under 
high-stringency  conditions with riboprobe transcribed  from 
the LAR alternative 3' untranslated region revealed the pres- 
ence of an ,,o5-kb transcript in cortex,  cerebellum,  and sev- 
eral peripheral organs (Fig. 9 A). This ,,o5-kb transcript most 
likely  contained  ,,ol  kb of additional  sequence  upstream of 
the starting point of the clone pRLAR4.0  insert,  predicting 
a  significantly  truncated LAR receptor with most of the ex- 
tracellular  domain deleted  (Fig.  1).  Developmental  regula- 
tion of the ~o5-kb alternative 3' untranslated region transcript 
was confirmed by two additional Northern blots with cortex 
and cerebellum  poly(A)  RNA  which  showed that this tran- 
script was most abundant at P21  in the cortex  and at P0  in 
the  cerebellum  (Fig.  9  A).  Expression  of the  ,,o5-kb  tran- 
script in peripheral organs was not quantitated,  although this 
transcript  appeared  to  be  more  abundant  in  several  non- 
neural tissues,  especially  in lung. 
Zhang and  Longo Regulation of LhR Alternative Splicing  425 Figure 9. Northern and Western analysis of RLAR isoforms.  Poly(A) RNA was isolated from the indicated tissue and PC12 cells (control 
cells  and following NGF treatment for 1, 3, and 5 days) and 4 ~g of each preparation was loaded per lane.  The blot with organ RNA 
(obtained from Clontech)  contained approximately  2 #g poly(A) RNA per lane.  The location of RNA size markers is shown on the left 
of each blot. The lower panel for each blot represents  the same blot reprobed with a cyclophilin riboprobe to control for loading variation. 
(A) Blots were probed with an antisense  riboprobe transcribed from a construct containing the alternative  3' untranslated  region found 
in LAR clone pRLAR4.0 and washed under high stringency conditions  as described under Materials  and Methods.  (B) Blots were probed 
with a 33-nucleotide  antisense  probe corresponding to the LASE-a 33-bp insert.  (C) Poly(A) RNA isolated  from adult cortex and 4 #g 
loaded per lane. The blot on the left was probed with a 37-nucleotide antisense probe corresponding to the LASE-c 27-bp insert and including 
five additional  nucleotides  on each side corresponding sequence  flanking LASE-c. The blot on the fight was probed with a 75-nucleotide 
antisense probe corresponding to the 75-bp LASE-d insert.  (D) Western blot analysis with LASE-a and LASE-c antibodies.  Protein extract 
from neonatal rat cerebellum was immunoprecipitated  with LASE-a antiserum (left) and resolved by SDS gel electrophoresis.  The resulting 
immunoblot was hybridized with crude LASE-a antiserum followed by incubation  with alkaline phosphatase-linked  goat anti-rabbit IgG. 
Bands were visualized  by incubation  with chemiluminescent  substrate  followed by exposure  to x-ray film for 15 min (see Materials  and 
Methods).  The same protein extract was also directly resolved by SDS gel electrophoresis  and the resulting  immunoblot hybridized with 
affinity-purified  LASE-c antibody (right). For lane 1, antibody was pre-incubated  with LASE-c peptide;  lane 2 is without peptide  pre- 
incubation. 
Northern Analysis Also Suggests Developmental 
Regulation of  LAR Isoforms 
Northern  analysis  was  conducted  with  a  LASE-a  33- 
nucleotide antisense  probe (Fig.  9  B).  LASE-a was found 
predominantly in the ,x,8-kb LAR isoform; a faint signal was 
detected at ~5 kb, consistent with the presence of LASE-a 
in transcripts represented by the pRLAR4.0 clone. Two addi- 
tional  Northern blots  with cortex and cerebellum  poly(A) 
RNA also showed that, compared to cyclophilin expression, 
LASE-a expression  decreased  during  development.  Three 
separate Northern analyses using PC12 poly(A) RNA dem- 
onstrated  that LASE-a expression  decreased  during  NGF- 
induced  PC12  differentiation.  The  developmentally  regu- 
lated  decrease  in  LASE-a  abundance  as  determined  by 
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consistent with our findings using RT-PCR. Previous North- 
ern blot studies using probe corresponding to the Y end 
of constitutive LAR demonstrated ~8-  and  ~o7-kb bands 
(Longo et al., 1993).  The *7-kb band is likely to represent 
LAR transcripts with FNIII domains 4, 6, and 7 (~o900 bp) 
deleted. These Northern studies demonstrated that during 
development the ~7-kb band signal decreased in proportion 
to the *8-kb band, consistent with the RT-PCR findings re- 
ported here (Fig.  7 and 8).  Overall, developmental changes 
measured by RT-PCR studies were consistent with Northern 
analyses. 
Northern analysis of adult cortex poly(A) RNA with an 
oligonucleotide antisense probe corresponding to LASE-c 
identified transcripts of ~7 kb, ~5 kb, and several shorter 
transcripts  with faint signal including those at  ~2.5  and 
,,o2.3 kb (Fig. 9 C). Analysis of the same RNA with a 75- 
nucleotide  antisense  probe  corresponding  to  the  75-bp 
LASE-d insert detected a prominant band at ~2.5 kb and a 
faint band at ~4 kb (Fig. 9 C). A 40-nucleotide antisense 
probe  containing only the 40-most downstream bases  of 
LASE-d also identified the *2.5-kb band and further sup- 
ported the identity of  this band as LAR (not shown). The sig- 
nal observed at 'x~2.5 kb using both LASE-c and LASE-d 
probes suggested that LAR transcripts existed that contain 
both LASE-c and LASE-d. Since the ~,o2.5-kb signal gener- 
ated by the LASE-c probe was faint, RT-PCR was used to 
determine if transcripts existed containing both LASE-c and 
LASE-d.  RT-PCR  using a  27-nucleotide upstream primer 
corresponding to LASE-c and the 40 nucleotide antisense 
oligonucleotide corresponding to LASE-d for a downstream 
primer  yielded  product  of predicted  size  and  therefore 
confirmed the existence of LAR transcripts containing both 
LASE-c and LASE-d. 
LASE-a and LASE-c Inserts Are Present in 
LAR Protein 
LAR protein is cleaved intracellularly into a ,'~150-kD ex- 
tracellular  subunit  containing  the  immunoglobulin  and 
FNIII domains and a ~85-kD subunit containing a short seg- 
ment of the extracellular region, the transmembrane region 
and the cytoplasmic domains (Streuli et al., 1992; Yu et al., 
1992).  If LASE-a  and  LASE-c  inserts  were  translated, 
LASE-a antibodies would be expected to identify the "°85- 
kD subunit and LASE-c antibodies an ~olS0-kD subunit. As 
shown in Fig. 9 D, LASE-a antisera (but not pre-immune 
sera)  precipitated  a  ~85-kD  protein,  demonstrating that 
LASE-a amino acids are present in LAR protein. Affinity- 
purified LASE-a antibody also  specifically identified the 
*85-kD protein (not shown). Affinity-purified  LASE-c anti- 
body hybridized with a ,'o150-kD protein, demonstrating that 
LASE-c amino acids are also present in LAR protein. Previ- 
ous studies demonstrating the ,,o85- and ~150-kD cleavage 
products of LAR examined LAR expression by cultured cells 
(Streuli et al.,  1992;  Yu et al.,  1992).  The present study 
demonstrated that LAR also undergoes cleavage in brain tis- 
sue in vivo. 
Given the '~2.5-kb  transcript demonstrated by LASE-d 
probes and the concomitant presence of LASE-c and LASE-d 
in LAR transcripts, LASE-c antibodies would be predicted 
to recognize an additional protein considerably smaller than 
the ,,o150-kD species. RT-PCR demonstrated that LASE-d is 
present in LAR transcripts containing FNHI domains 5-8 
(Fig.  8).  If stop codons in LASE-d caused termination of 
translation immediately downstream of FNHI domain 5, the 
,x,1 kb of transcript corresponding to FNIII domains 6-8 
would not be translated. A LASE-d containing transcript of 
•2.5  kb, would therefore have ,,ol.5 kb of transcript avail- 
able for open reading frame and 573' untranslated regions 
(Fig. 1). Thus, LASE-d containing transcripts would be ex- 
pected to generate protein(s) in the range of 40-50 kD. As 
this analysis predicted, affinity purified LASE-c antibodies 
also identified proteins of ,~42  and ,,o49 kD  (Fig.  9  D). 
These smaller proteins could represent LAR protein iso- 
forms truncated at the LASE-d insert prior to the transmem- 
brane domain. Their direct identification will require protein 
sequencing. Since the LASE-d insert predicted the addition 
of only two amino acids before the first stop codon is reached 
(Fig. 3), no attempt was made to raise LASE-d specific an- 
tisera. 
Splice Junction Sequence Analysis 
RT-PCR  studies  suggested that LASE-b containing LAR 
transcripts were very rare compared to those with LASE-a. 
We determined whether the presence  of strong or  weak 
splice donor or acceptor sites (Smith et al., 1989) correlated 
with this trend by cloning and sequencing introns flanking 
these alternatively spliced exons (Fig.  10). Intron analysis 
demonstrated that the splice acceptor site immediately up- 
stream from LASE-b, which would be used for its retention, 
had  fewer pyrimidines  (7/12) than  typical acceptor  sites 
(11-12/12) while the acceptor site downstream, which would 
be used to eliminate LASE-b, had a more typical consensus 
sequence (11/12 pyrimidines). In contrast, the acceptor site 
upstream  from LASE-a  had a  favorable sequence  (11/12 
pyrimidines). This finding was consistent with the very low 
abundance of LASE-b containing transcripts, although other 
cis elements as well as trans-acting factors are also likely to 
regulate LASE-a and LASE-b splicing.  The  LASE-d re- 
tained intron was also further characterized at the genomic 
DNA level (Fig.  10). Genomic sequence revealed that FNIII 
domains 6 and 7  were present in the same exon and that 
LASE-d  served  as  the  intron  between  FNNI  domains 5 
and 6-7. 
Discussion 
This  study  demonstrates  tissue-preferential  and  highly- 
regulated LAR alternative splicing evident at both the mRNA 
and protein level. An over-view of splice variant regulation 
reveals several patterns which suggest specialized functions 
for LAR in the nervous system and support our hypothesis 
that LAR has a role in neural development (Table I). First, 
all six identified alternatively spliced forms of  LAR occurred 
preferentially in neural or neuromuscular tissue. Expression 
of LASE-b, LASE-c, LASE-d, and FNIII deletions 4 and 6-7 
was compared in cultured neurons and astrocytes. With the 
exception of  LASE-d, which was not detected in either neurons 
or astrocytes, each alternative isoform examined was prefer- 
entially expressed in neurons. In situ hybridization studies 
with LASE-specific probes, in progress, will establish whether 
LASE expression is also neuronal-selective in vivo. In initial 
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Consensus  seq:  MAG 
LASE-a 
IVS-2:  CAG 
IVS-3:  CAA 
LASE-b 
IVS-4:  GAG 
IVS-5:  AAG 
FNIII 6-7 
LASE-d:  CAG 
IVS-I:  AAG 
Splice  Splice 
donor  acceptor 
gtragt  yyyyyyyyyyyy  n  yag 
gtaagg  tttgttttctct  g  cag 
gtaagt  tctccacctccc  c  tag 
gtgagt  gtctctcgggac  c  tag 
gtagga  cgtctttcttct  t  tag 
gtgagt  agtgcgtgctgt  t  cag 
gtgtgt  cctcatgcttccacag 
# Pyrimidinel 
G 
G  11/12 
G  11112 
T  7/12 
G  11/12 
T  6/12 
T  10/12 
Figure 10.  Analysis of introns flanking LASEs. Nucleotide se- 
quences of LASE exon-intron  boundaries. (A) LASE-a  and LASE-b 
are alternatively spliced cassette exons. Alternative splicing is in- 
dicated by thin lines and constitutive slicing is shown by heavy 
lines. LASE-d contains in-frame stop codons and therefore is a re- 
talned intron. FNIB domains 6 and 7 are contained in one exon. 
(/VS, intervening intron sequence). (B) Splice junction sequence. 
RT-PCR (Figs. 4 and 5) demonstrated that LASE-b was rarely re- 
tained in LAR transcripts compared to LASE-a. The weak splice 
acceptor site upstream of LASE-b (7/12 pyrimidines, IVS-4) com- 
pared to the downstream acceptor site (11/12 pyrimidines, WS-5) is 
consistent with the relatively low abundance of LASE-b containing 
transcripts. Upper case, exon sequence; /, splice junction; lower 
case, intron sequence; Y, pyrimidines  C or T; M, A or C; R, purines 
A or G. 
in situ studies of LASE-a and LASE-c, both were predomi- 
nantly expressed by specific subsets of neurons (Zhang, J. S., 
and E  M. Longo, unpublished observations). Preliminary 
immunohistology  studies  with  antibodies  raised  against 
LASE-a and LASE-c peptides also suggest selective neuronal 
LASE-a and LASE-c expression. 
Second, all six LAR alternative splicing forms were de- 
velopmentally regulated, suggesting that some isoforms are 
more characteristic of developmental processes and others 
are more typical of the adult or stabilized nervous system. 
It is especially interesting to note that proportions of five out 
of five variants examined in muscle shifted toward "develop- 
mental" isoforms following denervation (Table I, columns 1 
and 5). This finding is analogous to N-CAM reversion to em- 
bryonic forms following peripheral nerve transection (Nieke 
and Schachner, 1985) and raises the possibility of LAR in- 
volvement in neurite-target interactions during development 
or regeneration. Nerve transection-induced alternative splicing 
in distal nerve segments suggests that specific LAR isoforms 
are involved in regenerative neurite outgrowth through dener- 
vated nerve (Table I, columns 1 and 4). 
Third, all five splice variants detected in 3T3 fibroblasts 
were regulated by degree of cell confluence and confluence 
caused a shift toward "developmental"  arrangements of FNIR 
domains. Several observations suggest that receptor-linked 
Table L  Coordination  of Cell Growth State and Novel 
LAR lsoforms 
During  NGF-induced  3T3FB  Nerve  Muscle, 
CNS  PCI2  reaching  post-  post- 
development  differentiation  confluence  denervation  denervation 
LASE-a  ~¢  ~¢  --  ¢  ¢  (SNE) 
8 
.~  LASE-b  ¢  ¢  ~  --  -- 
LASE..c  ~  ¢  ¢  not  ¢ 
detected 
LASE-d  detected  detected 
FNIII  4 
deletion  ~  ¢  ¢ (SNE)  ¢  ¢ 
0  -f  -  -  -  -  i-  - 
deletion 
Statistically significant changes in proportion of LAR transcripts containing 
each splice variant as determined by RT-PCR. A dash (-) indicates not tested 
and SNE indicates statistical significance  not established. Data from Figs. 4-8 
are summarized. 
PTPs provide a mechanism by which cell-cell contact inhibits 
cell proliferation: (a) some receptor-linked PTPs contain cell 
adhesion molecule motifs; (b) tyrosine phosphatase activity 
in 3T3 fibroblasts is increased in confluent growth-arrested 
cells compared to activity in low density proliferating cells 
(PaUen and Tong, 1991); (c) LAR mRNA expression in 3T3 
fibroblasts in increased by cell confluence (Longo et al., 1993); 
and (d) conditions causing decreased ceLl-substrate adhesion 
lead to activation of tyrosine phosphatases (Maher,  1993). 
The role of FNRI repeats in promoting cell spreading (Frei 
et al., 1992) and regulation of LAR FNIR domain splicing 
by cell confluence shown in this study raises the possibility 
that  LAR  mediates  and/or  responds  to  cell-cell  and/or 
cell-substrate interactions. 
Modulation of alternative LAR splicing occurs at the cel- 
lular level. The developmental changes in LAR splice pat- 
terns seen in brain tissues could have resulted from changing 
proportions of specific cell populations, each consistently ex- 
pressing a given set of LAR isoforms. Instead, alternative 
splicing may be regulated during differentiation  of  a given cell 
type. The latter mechanism is consistent with our observa- 
tion that all five splice variants found in PC12 cells were regu- 
lated during NGF-induced differentiation. For both intra- 
cellular domain variants  (LASE-a and LASE-b),  in vivo 
developmental changes paralleled changes seen during PC12 
cell differentiation. For all three extracellular domain vari- 
ants however, in vivo and PC12 cell development demonstrated 
opposite trends. The difference between in vivo and PC12 cell 
splicing regulation of extracellular domains may be related 
to the fact that in vivo development during this time period 
includes events occurring subsequent to neurite outgrowth 
such as synaptogenesis (Jacobson,  1978).  Such additional 
events may be associated with different splice patterns. LAR 
splicing may be regulated differentially in different neuronal 
populations. 
A cell surface molecule with a large number of isoforms 
would be an important candidate for mediating specific and 
highly regulated cell-cell or cell-extracellular matrix inter- 
actions. Studies by Zisch et at. (1992) suggested that alterna- 
tive splicing of FNIII repeats in the extracellular matrix pro- 
tein, tenascin, regulated its binding affinity to the neuronal 
surface glycoprotein contacfin/F11. N-CAM expression studies 
with constructs containing both or either FNIII domains 
demonstrated that the combination of both N-CAM FNIII 
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compared to individual domains (Frei et al., 1992), thereby 
suggesting that different  combinations of  repetitive FNIII units 
may differentially  regulated neurite outgrowth. However, de- 
velopmentally regulated or tissue-specific alternative splicing 
of FNIII domain cassettes within N-CAM itself or within 
receptor-linked PTPs has not been demonstrated. 
Developmentally regulated and nervous system-preferential 
combinatorial use of LAR FNIII domain cassette exons con- 
stitutes a candidate novel mechanism for regulating neurite 
outgrowth and establishing specific axonal connections. Com- 
binatorial use of LASE-a, -b, and -c exons and the FNIII 4 
and 6-7 domains could potentially give rise to 32 different 
LAR isoforms with four additional isoforms if LASE-d led 
to a truncated protein. The existence of eDNA clones con- 
taining both  LASE-a and LASE-b or containing LASE-a 
without LASE-b (Fig. 1) demonstrated that splicing of some 
exons can occur independently. Independent exon use was fur- 
ther suggested by opposite trends in the proportion of LAR 
transcripts containing FNIII domain 4 compared to domains 
6-7 in nerve and muscle following nerve transection. Within 
a specific brain or tissue region, different cells may differen- 
tially splice LAR; therefore, determination of the actual ex- 
tent of LAR isoform variability will require further studies 
in uniform cell populations. 
The LASE-c extracellular exon has several features similar 
to the N-CAM variably alternatively spliced exon (VASE). 
This exon contributes a 10-amino acid segment to N-CAMS's 
fourth Ig domain and its expression increases during devel- 
opment (Small and Akeson, 1990). Findings that incorpora- 
tion of VASE inhibits N-CAM's neurite-promoting effect led 
to the suggestion that VASE may negatively modulate syn- 
aptic plasticity and promote stability of the adult nervous 
system (Doherty et al.,  1992;  Doherty and Walsh,  1994). 
Within N-CAM, Ig domains predominantly regulate cell adhe- 
sion and FNIII domains contribute significantly  to neurite out- 
growth (Frei et al.,  1992).  It is not known if LAR affects 
neurite outgrowth, although the developmentally regulated 
expression of  the LAR protein along axons during Drosophila 
development and the preferential expression of LASE-c in 
neurons and neural tissue raises the possibility that LASE-c 
splicing into LAR FNIII domain 5 may somehow alter its func- 
tion and thereby modulate neurite outgrowth. Differences be- 
tween LASE-c and VASE include: VASE is not expressed in 
PC12 cells (Small and Akeson, 1990) and since N-CAM it- 
self  is not expressed over a broad range of  non-neuronal tissue, 
VASE splicing cannot be viewed as nervous system preferen- 
tial. Expression of LAR constructs with and without LASE-c 
and current characterization of LASE-c antibodies will con- 
tribute to LAR functional studies. 
Like virtually all members of  the receptor PTP gene family, 
the ligand(s) for the LAR receptor has not been identified. 
The existence of a secreted LAR isoform would raise the pos- 
sibility that soluble LAR could function as an LAR ligand 
by homophilic interaction. Therefore, it was of particular in- 
terest to discover an mRNA transcript which predicted the 
expression of a soluble extracellular isoform. The LASE-d 
retained intron included two in-frame stop codons that would 
prematurely terminate protein translation upstream from the 
hydrophobic transmembrane domain, between FNIII domains 
5 and 6. In studies of  rat N-CAM, Gower et al. (1988) demon- 
strated that an extracellular domain alternatively spliced ele- 
ment contained an in-frame stop codon and generated a 
secreted isoform. Determining whether LASE-d containing 
LAR transcripts actually generate secreted LAR will require 
further studies at the protein level. Our observation that LASE-d 
splicing is preferential to neural and muscle tissue and that 
it is modulated during development and subsequent to dener- 
vation supports the notion that a secreted LAR isoform may 
have a physiological role. 
Alternative  splicing  in  the  juxtamembrane  region  of 
receptor-linked PTPs has not been previously reported. There 
are several possible functions for splicing of the predicted 
LASE-a 11 amino acids and LASE-b 4 amino acids into the 
intracellular juxtamembrane region of LAR. First, these in- 
serts could influence the intracellular location of LAR by 
promoting interaction with other proteins such as cytoskeletal 
elements. Screening of these sequences did not reveal known 
cytoskeletal-interaction  motifs (Luna and Hitt, 1992) or other 
motifs influencing intraceUular location (Mauro and Dixon, 
1994).  Second, inserts could modulate LAR-LAR interac- 
tion, such as clustering, and thereby regulate LAR function. 
Third, the presence of these inserts could change LAR pro- 
tein structure and thereby alter activity of  the nearby tyrosine 
phosphatase domain. Fourth, serines introduced by LASE-a 
(SSAPSCPNISS) and LASE-b (SKQE) represent potential 
substrates for Ser/Thr kinases. While these serines are not 
a part of known substrate consensus sequences for protein 
kinases (Aitken, 1990), protein kinases such as cyclin-p34 ~2 
can phosphorylate serines located outside of  known consensus 
motifs (Satterwhite et al., 1992).  Finally, the presence of a 
cysteine residue in LASE-a raises the possibility of receptor 
oligomerization mediated by disulfide bond formation. For 
example, Ltk transmembrane tyrosine kinase is activated by 
the formation of disulfide-linked multimers (Bauskin et al., 
1991). 
Another unexpected finding of these studies of LAR iso- 
forms was the presence of an alternative 3' untranslated re- 
gion containing extensive tandem CAG repeats. Expansion 
of  unstable GC-rich tandem trinucleotide repeats during DNA 
replication has recently been found to be the cause of sev- 
eral currently identified neurological disorders (reviewed in 
Richards and Sutherland, 1992; Martin, 1993; Miwa, 1994). 
Interestingly, in five of these diseases (Huntington's disease, 
spinobulbar muscular atrophy, spinocerebellar ataxia type 1, 
dentatorubral-paUidoluysian  atrophy, and myotonic dystrophy) 
a CAG repeat expands. Two mechanisms have been proposed 
to cause expansion of tandem repeats: (a) unequal crossing- 
over between misaligned allelic tandem arrays producing one 
tandem array with more repeats; and (b) DNA polymerase 
slippage in which transient dissociation of  template and primer 
strands during DNA replication followed by misaligned rean- 
nealing leads to expanded tract lengths without non-repeat 
intervening sequence (Wells and Sinden, 1993; Richards and 
Sutherland, 1994). The presence of the 30-bp super repeats 
in association with the LAR CAG repeats is of interest be- 
cause  super-repeats  have  not  been  observed  in  repeat- 
containing genes described thus far and they suggest that the 
first mechanism was at least one process contributing to the 
formation of the rat LAR CAG repeat region. 
The number of tandem repeats in normal alleles of genes 
associated with CAG repeat disorders ranges from 5 to 37. 
In general, repeat length correlates with degree of instability 
and tendency to expand (Richards and Sutherland,  1992, 
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trinucleotide repeat genes has yielded some 15-20 additional 
genes (Riggins et al., 1992; Li et al., 1993).  These repeats 
were polymorphic and most frequently consisted of  only 5-10 
uninterrupted tandem repeats; the greatest number reported 
was 18. Thus, our finding of up to 24 tandem CAG repeats 
in the rat LAR gene is greater than that seen in most non- 
disease-related genes and well within the range of  the normal 
alleles of the disease-related genes. The LAR CAG repeats 
are also unusual in that they are present in the context of an 
exonic ,,o800-bp CG-rich, and therefore potentially unstable, 
region. The conservation of the 3' untranslated region CAG 
repeat in the human and mouse myotonic dystrophy genes 
(Jansen et al., 1992) raises the possibility that the repeat found 
in the rat LAR gene is also present in the human gene. 
The discovery of extensive CAG repeats in a gene poten- 
tially involved in neurodevelopment would be of particular 
interest in light of studies demonstrating the existence of an- 
ticipation in several neuropsychiatric disorders (Zheng et al., 
1993).  It is also intriguing to note that PTPs may function 
as tumor suppressor genes (Walton and Dixon, 1993) and that 
the chromosomal location of  human LAR at lp32-33 (Streuli 
et al., 1992; Jirik et al., 1992) is similar to the loci for candi- 
date tumor suppressor genes which may be disrupted in sev- 
eral malignancies including neuroblastoma, pheochromocy- 
toma, some astrocytomas, and ductal breast cancer (Matthew 
et al., 1987; Rittke et al., 1989; Moley et al., 1992; Kimmel 
et al., 1992).  Current analysis of human 3' untranslated re- 
gion cDNA and genomic LAR clones isolated in our labora- 
tory will determine if extensive CAG repeats are also present 
in the human LAR gene. 
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